A Multicenter, Prospective, Observational, Post Marketing Surveillance Study to Evaluate the Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Patients With Chronic Hepatitis C Virus Infection in India

Status: Completed
Location: See all (26) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This study will evaluate the safety and efficacy of sofosbuvir (SOF)-based regimens administered as per the approved prescribing information in adults with chronic hepatitis C virus (HCV) infection treated in routine clinical practice in India.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• HCV-infected patients living in India

• Treatment with a SOF-based regimen as determined by the patient's treating physician per the approved prescribing information.

• Patients who provide written and signed informed consent prior to initiation of treatment where required.

Locations
Other Locations
India
Sanjivani Superspeciality Hospital Clinical Research Department
Ahmedabad
Saviour Hospital
Ahmedabad
BGS global Hospitals
Bengaluru
Manipal Hospital
Bengaluru
Postgraduate Institute of Medical Education and Research
Chandigarh
Global Hospitals & Health City
Chennai
Sri Ramachandra Medical College and Research
Chennai
VGM Hospital
Coimbatore
Artemis Hospital
Gurgaon
Aware Global Hospital
Hyderabad
Global Hospitals
Hyderabad
Marudhar Hospital
Jaipur
S.R. Kalla Memorial Gastro & General Hospital
Jaipur
SMS Medical College & Hospital
Jaipur
Lakeshore Hospital
Kochi
Institute of Post Graduate Medical Education And Research
Kolkata
K. R. M. Hospital & Research Centre
Lucknow
KGMU Medical College
Lucknow
M.V. Hospital and Research Centre
Lucknow
Dayanand Medical College & Hospital
Ludhiana
BYL Nair Hospital & T N Medical College
Mumbai
Midas Institute of Gastro-enterology
Nagpur
A.I.I.M.S.
New Delhi
Sir Ganga Ram Hospital
New Delhi
Nirmal Hospital Pvt. Ltd.
Surat
Om Research Center, Om Surgical Center & Maternity Home
Varanasi
Time Frame
Start Date: 2015-11-30
Completion Date: 2018-04-23
Participants
Target number of participants: 532
Treatments
SOF-based regimens
Adults with chronic HCV infection in India who are being treated with a SOF-based treatment regimen as per the approved prescribing information.
Related Therapeutic Areas
Sponsors
Leads: Gilead Sciences

This content was sourced from clinicaltrials.gov